These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17111450)

  • 1. Is the ferric hydroperoxy species responsible for sulfur oxidation in cytochrome p450s?
    Cryle MJ; De Voss JJ
    Angew Chem Int Ed Engl; 2006 Dec; 45(48):8221-3. PubMed ID: 17111450
    [No Abstract]   [Full Text] [Related]  

  • 2. Which oxidant is really responsible for sulfur oxidation by cytochrome P450?
    Li C; Zhang L; Zhang C; Hirao H; Wu W; Shaik S
    Angew Chem Int Ed Engl; 2007; 46(43):8168-70. PubMed ID: 17886330
    [No Abstract]   [Full Text] [Related]  

  • 3. Products of cytochrome P450(BioI) (CYP107H1)-catalyzed oxidation of fatty acids.
    Cryle MJ; Matovic NJ; De Voss JJ
    Org Lett; 2003 Sep; 5(18):3341-4. PubMed ID: 12943422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate-controlling isomerizations in fatty acid oxidations by a cytochrome P450 compound I.
    Su Z; Chen X; Horner JH; Newcomb M
    Chemistry; 2012 Feb; 18(9):2472-6. PubMed ID: 22298496
    [No Abstract]   [Full Text] [Related]  

  • 5. Are branched chain fatty acids the natural substrates for P450(BM3)?
    Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
    Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oxidation reactions catalyzed by cytochrome P-450 on fatty acids and leukotrienes: implications in inflammatory mechanisms].
    Delaforge M; Reigneau O
    Ann Med Interne (Paris); 1988; 139(7):492-8. PubMed ID: 3245648
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanistic insight into formation of oxo-iron(IV) porphyrin pi-cation radicals from enzyme mimics of cytochrome P450 in organic solvents.
    Hessenauer-Ilicheva N; Franke A; Meyer D; Woggon WD; van Eldik R
    Chemistry; 2009; 15(12):2941-59. PubMed ID: 19185039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclopropyl containing fatty acids as mechanistic probes for cytochromes P450.
    Cryle MJ; Ortiz de Montellano PR; De Voss JJ
    J Org Chem; 2005 Apr; 70(7):2455-69. PubMed ID: 15787531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental documentation of the structural consequences of hydrogen-bonding interactions to the proximal cysteine of a cytochrome P450.
    Mak PJ; Yang Y; Im S; Waskell LA; Kincaid JR
    Angew Chem Int Ed Engl; 2012 Oct; 51(41):10403-7. PubMed ID: 22968976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel.
    Haines DC; Chen B; Tomchick DR; Bondlela M; Hegde A; Machius M; Peterson JA
    Biochemistry; 2008 Mar; 47(12):3662-70. PubMed ID: 18298086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How does the axial ligand of cytochrome P450 biomimetics influence the regioselectivity of aliphatic versus aromatic hydroxylation?
    de Visser SP; Tahsini L; Nam W
    Chemistry; 2009; 15(22):5577-87. PubMed ID: 19347895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes.
    Meunier B; de Visser SP; Shaik S
    Chem Rev; 2004 Sep; 104(9):3947-80. PubMed ID: 15352783
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions of substrates at the surface of P450s can greatly enhance substrate potency.
    Hegde A; Haines DC; Bondlela M; Chen B; Schaffer N; Tomchick DR; Machius M; Nguyen H; Chowdhary PK; Stewart L; Lopez C; Peterson JA
    Biochemistry; 2007 Dec; 46(49):14010-7. PubMed ID: 18004886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decarboxylation of fatty acids to terminal alkenes by cytochrome P450 compound I.
    Grant JL; Hsieh CH; Makris TM
    J Am Chem Soc; 2015 Apr; 137(15):4940-3. PubMed ID: 25843451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative structure-activity relationships of cytochrome P-450.
    Hansch C; Zhang L
    Drug Metab Rev; 1993; 25(1-2):1-48. PubMed ID: 8449144
    [No Abstract]   [Full Text] [Related]  

  • 16. High-valent iron(IV)-oxo complexes of heme and non-heme ligands in oxygenation reactions.
    Nam W
    Acc Chem Res; 2007 Jul; 40(7):522-31. PubMed ID: 17469792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greatly reduced amino acid alphabets in directed evolution: making the right choice for saturation mutagenesis at homologous enzyme positions.
    Reetz MT; Wu S
    Chem Commun (Camb); 2008 Nov; (43):5499-501. PubMed ID: 18997931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity patterns of cytochrome P450 enzymes: multifunctionality of the active species, and the two states-two oxidants conundrum.
    Shaik S; Hirao H; Kumar D
    Nat Prod Rep; 2007 Jun; 24(3):533-52. PubMed ID: 17534529
    [No Abstract]   [Full Text] [Related]  

  • 19. Crystal structure of CYP199A2, a para-substituted benzoic acid oxidizing cytochrome P450 from Rhodopseudomonas palustris.
    Bell SG; Xu F; Forward I; Bartlam M; Rao Z; Wong LL
    J Mol Biol; 2008 Nov; 383(3):561-74. PubMed ID: 18762195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monovalent iron in a sulfur-rich environment.
    Mock MT; Popescu CV; Yap GP; Dougherty WG; Riordan CG
    Inorg Chem; 2008 Mar; 47(6):1889-91. PubMed ID: 18275141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.